Stock Medication for the Isle of Wight Sexual Health Service

2. II.2.14.1

'This This is a Provider Selection Regime (PSR) intention to confirmation of contract award notice. The awarding of this This contract is subject to has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice.Representations by providers must be made to decision makers by 24/03/2025. This contract has not yet formally now been awarded; this notice serves as an intention to formally awarded using direct award under the PSR.’ Written representations should be sent to commercial@solent.nhs.ukAward decision makers included Operational Director for Sexual Health, Finance Business Partner, Commercial Business Partner, Director of Procurement and Chief Finance Officer.No conflicts of Interest were registered.Relative importance of the key criteria was established by Hampshire and Isle of Wight Healthcare NHS Foundation Trust. process C.This standstill period ended on 24 March 2025. This took into account a set of evaluated criteria to determine:The providers ability to pursue the particular activity including CQC Status, insurance, licences and registrations, and DBS clearenceEconomic and financial standing through account validation and financial checksTechnical and professional ability through evidence of qualifications and trainingAppropriateness of service delivery through reviewing existing relevant experience and performanceAdditional checks were made and ratified against quality and innovation, value The contract term is for money, Integration, collaboration and service sustainability, Improving access/reducing health inequalities and social value. 6 years. The value of this contract is £535,104